Avandia combined with Glipizide

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Overdose Other Serious 1/1/2000 71 Male 201 lb 1/3/2006 Lawyer United States
Primary
Concomitant
Visual Acuity Reduced Other Serious 1/1/2003 59 Male 1/10/2006 Consumer United States
Primary
Concomitant
Coronary Artery Occlusion Other Serious 1/1/2004 58 Male 185 lb 1/10/2006 Lawyer United States
Primary
Concomitant
Pericarditis Other Serious 1/1/2005 Male 237 lb 1/11/2006 Physician United States
Primary
Secondary
Concomitant
Weight Increased Other Serious 10/17/2005 Male 1/11/2006 Physician United States
Primary
Secondary
Concomitant
Vision Blurred Other Serious 6/1/2005 61 Male 1/13/2006 Consumer United States
Primary
Concomitant
White Blood Cells Urine Positive Hospitalization 6/1/2005 66 Male 1/4/2006 Other Health Professional United States
Primary
Secondary
Concomitant
Urine Output Decreased Hospitalization 12/13/2005 93 Female 12/23/2005 Pharmacist United States
Primary
Concomitant
Yellow Skin Other Serious 76 Female 1/19/2006 Consumer United States
Primary
Concomitant
Surgery Hospitalization 1/1/2001 58 Male 240 lb 1/23/2006 Physician United States
Primary
Concomitant
Somnolence Hospitalization 12/19/2005 85 Female 1/24/2006 Consumer United States
Primary
Concomitant
Pulmonary Congestion Hospitalization 1/1/2005 Female 108 lb 2/7/2006 Other Health Professional United States
Primary
Concomitant
Depression 5/1/2005 47 Female 2/8/2006 Consumer United States
Primary
Concomitant
Treatment Noncompliance 1/1/2001 Female 2/8/2006 Consumer United States
Primary
Secondary
Concomitant
Skin Exfoliation Hospitalization 80 Male 2/16/2006 Consumer United States
Primary
Concomitant
Transient Ischaemic Attack Other Serious 11/1/2002 53 Male 214 lb 2/16/2006 Lawyer United States
Primary
Concomitant
Pericardial Effusion Other Serious 1/1/2003 75 Female 201 lb 2/23/2006 Physician United States
Primary
Concomitant
Tremor Other Serious 10/1/2005 51 Male 2/23/2006 Consumer United States
Primary
Secondary
Concomitant
Mental Status Changes Hospitalization 1/1/2005 Female 108 lb 3/6/2006 Physician United States
Primary
Concomitant
Injection Site Pain 11/25/2005 81 Female 125 lb 1/20/2006 Consumer United States
Primary
Concomitant
Systemic Lupus Erythematosus Other Serious 55 Female 3/13/2006 Consumer United States
Primary
Concomitant
Weight Decreased 12/13/2005 66 Female 1/20/2006 Consumer United States
Primary
Concomitant
Tremor 12/1/2005 48 Female 200 lb 1/20/2006 Consumer United States
Primary
Concomitant
Weight Decreased 11/25/2005 49 Female 1/20/2006 Consumer United States
Primary
Concomitant
Vision Blurred 11/18/2005 38 Male 1/10/2006 United States
Primary
Concomitant
Vitreous Haemorrhage Other Serious 3/1/2003 47 Male 3/21/2006 Consumer United States
Primary
Concomitant
Wound Other Serious 1/1/2005 78 Male 170 lb 3/2/2006 United States
Primary
Concomitant
Monoplegia Other Serious 1/1/2005 57 Female 3/23/2006 Consumer United States
Primary
Concomitant
Therapeutic Response Decreased Hospitalization 1/1/2005 Female 108 lb 3/24/2006 Physician United States
Primary
Concomitant
Peripheral Vascular Disorder Other Serious 1/1/2000 68 Male 201 lb 3/24/2006 Physician United States
Primary
Concomitant
Vomiting Hospitalization 1/1/2003 55 Male 172 lb 3/27/2006 Lawyer United States
Primary
Concomitant
Weight Decreased Other Serious 7/1/2000 67 Male 262 lb 3/24/2006 Physician United States
Primary
Secondary
Concomitant
Mitral Valve Prolapse Other Serious 4/1/2005 Female 137 lb 3/28/2006 Other Health Professional United States
Primary
Concomitant
Transient Ischaemic Attack Hospitalization 3/2/2004 45 Male 196 lb 3/29/2006 Lawyer United States
Primary
Concomitant
Myocardial Infarction Other Serious 1/1/2004 58 Male 185 lb 3/29/2006 Lawyer United States
Primary
Concomitant
Therapeutic Response Unexpected 1/1/2005 59 Male 1/20/2006 Physician United States
Primary
Secondary
Concomitant
Overdose Hospitalization 3/1/2003 60 Male 231 lb 3/30/2006 Lawyer United States
Primary
Concomitant
Decreased Appetite 11/20/2005 57 Male 214 lb 1/20/2006 Consumer United States
Primary
Concomitant
Weight Decreased 83 Female 160 lb 1/20/2006 Consumer United States
Primary
Concomitant
Early Satiety 11/15/2005 55 Male 1/20/2006 Consumer United States
Primary
Concomitant
Sinus Congestion 9/15/2005 59 Female 180 lb 1/20/2006 Consumer United States
Primary
Concomitant
Weight Decreased 10/12/2005 74 Male 235 lb 1/20/2006 Consumer United States
Primary
Concomitant
Injection Site Haemorrhage 11/16/2005 55 Female 305 lb 1/20/2006 Consumer United States
Primary
Concomitant
Nausea 11/6/2005 76 Male 1/20/2006 Consumer United States
Primary
Concomitant
Therapy Non-responder Life Threatening 7/29/2005 71 Female 3/31/2006 Other Health Professional United States
Primary
Concomitant
Weight Decreased 11/17/2005 74 Male 230 lb 1/20/2006 Consumer United States
Primary
Concomitant
Weight Decreased 1/1/2005 72 Female 174 lb 1/20/2006 Consumer United States
Primary
Concomitant
Weight Decreased 10/28/2005 59 Male 169 lb 1/20/2006 Consumer United States
Primary
Concomitant
Vomiting 11/11/2005 46 Female 220 lb 1/20/2006 Consumer United States
Primary
Concomitant
Nausea 10/9/2005 58 Female 250 lb 1/20/2006 Consumer United States
Primary
Concomitant
Tremor 12/1/2005 Female 1/20/2006 Physician United States
Primary
Concomitant
Blood Glucose Increased 11/1/2005 67 Male 190 lb 1/20/2006 Consumer United States
Primary
Concomitant
Vomiting 8/1/2005 62 Female 1/20/2006 Consumer United States
Primary
Concomitant
Weight Decreased 10/1/2005 53 Male 296 lb 1/20/2006 Physician United States
Primary
Concomitant
Nausea 10/2/2005 66 Male 1/20/2006 Consumer United States
Primary
Concomitant
Weight Decreased 1/1/2005 67 Male 190 lb 1/20/2006 Consumer United States
Primary
Secondary
Concomitant
Blood Glucose Increased 12/22/2005 50 Female 1/20/2006 Consumer United States
Primary
Concomitant
Weight Decreased 12/1/2005 65 Male 279 lb 1/20/2006 Consumer United States
Primary
Concomitant
Medication Error 10/8/2005 64 Female 285 lb 1/20/2006 Other Health Professional United States
Primary
Concomitant
Drug Effect Decreased 12/25/2005 73 Male 1/20/2006 Consumer United States
Primary
Concomitant
Blood Glucose Increased 12/31/2005 56 Male 265 lb 1/20/2006 Consumer United States
Primary
Concomitant
Weight Decreased 12/1/2005 42 Female 235 lb 1/20/2006 Consumer United States
Primary
Concomitant
Hypoaesthesia 12/12/2005 57 Male 315 lb 1/20/2006 Consumer United States
Primary
Concomitant
Transient Ischaemic Attack Hospitalization 11/6/2002 53 Male 214 lb 4/13/2006 Physician United States
Primary
Concomitant
Pain Other Serious 73 Female 121 lb 4/7/2006 United States
Primary
Secondary
Concomitant
Epistaxis Hospitalization 2/2/2006 54 Female 179 lb 4/7/2006 Pharmacist United States
Primary
Concomitant
Road Traffic Accident Hospitalization 9/25/2005 79 Male 170 lb 4/7/2006 Physician United States
Primary
Concomitant
Tachycardia Hospitalization 69 Female 198 lb 4/20/2006 Other Health Professional United States
Primary
Concomitant
Weight Increased Other Serious 10/17/2005 Male 4/28/2006 Physician United States
Primary
Secondary
Concomitant
Transient Ischaemic Attack Hospitalization 3/2/2004 45 Male 196 lb 5/1/2006 Physician United States
Primary
Concomitant
Pharmaceutical Product Complaint Hospitalization 3/20/2006 55 Female 208 lb 4/20/2006 Physician United States
Primary
Concomitant
Retinal Haemorrhage Other Serious 10/24/2005 62 Female 5/3/2006 Consumer United States
Primary
Concomitant
Vomiting Hospitalization 8/1/2005 67 Male 2/17/2006 Other Health Professional United States
Primary
Secondary
Concomitant
Vomiting Required Intervention 8/12/2005 67 Male 2/17/2006 Other Health Professional United States
Primary
Concomitant
Skin Exfoliation Hospitalization 80 Male 5/5/2006 Consumer United States
Primary
Concomitant
Stomach Discomfort Hospitalization 10/28/2002 68 Male 209 lb 5/10/2006 Physician United States
Primary
Concomitant
Neuralgia Other Serious 11/1/2005 56 Male 211 lb 5/8/2006 United States
Primary
Concomitant
Vomiting Hospitalization 3/20/2006 55 Female 208 lb 5/12/2006 Physician United States
Primary
Concomitant
Skin Exfoliation Hospitalization 12/1/2005 80 Male 175 lb 5/24/2006 Consumer United States
Primary
Concomitant
Anaemia Other Serious Female 5/24/2006 Consumer United States
Primary
Secondary
Somnolence 12/1/2005 59 Male 300 lb 4/3/2006 Consumer United States
Primary
Concomitant
Renal Failure Other Serious Female 5/31/2006 Consumer United States
Primary
Concomitant
Somnolence 1/9/2006 75 Female 204 lb 4/3/2006 Consumer United States
Primary
Concomitant
Weight Decreased 3/1/2006 70 Female 244 lb 4/17/2006 Consumer United States
Primary
Concomitant
Vomiting 1/28/2006 48 Male 201 lb 4/17/2006 Consumer United States
Primary
Concomitant
Pain In Extremity Hospitalization 3/1/2006 82 Female 6/15/2006 Consumer United States
Primary
Concomitant
Visual Acuity Tests Abnormal Other Serious 5/8/2006 65 Female 172 lb 6/19/2006 Consumer United States
Primary
Concomitant
Pancreatitis Hospitalization 1/31/2006 63 Male 4/24/2006 United States
Primary
Concomitant
Treatment Noncompliance Hospitalization 5/28/2006 50 Female 6/13/2006 Other Health Professional United States
Primary
Concomitant
Vision Blurred Other Serious 4/1/2006 78 Male 145 lb 6/27/2006 Physician United States
Primary
Secondary
Concomitant
Decreased Appetite 1/30/2006 57 Male 215 lb 4/17/2006 Consumer United States
Primary
Concomitant
Weight Decreased 12/6/2005 58 Female 219 lb 4/17/2006 Consumer United States
Primary
Concomitant
Vomiting 11/1/2005 51 Female 209 lb 4/17/2006 Consumer United States
Primary
Concomitant
Weight Decreased 1/27/2006 58 Female 166 lb 4/17/2006 Consumer United States
Primary
Concomitant
Weight Decreased 1/11/2006 62 Female 197 lb 4/17/2006 Consumer United States
Primary
Concomitant
Weight Decreased 12/1/2005 62 Male 201 lb 4/17/2006 Consumer United States
Primary
Concomitant
Tremor 1/31/2006 60 Male 156 lb 4/17/2006 Consumer United States
Primary
Concomitant
Swollen Tongue 2/2/2006 76 Female 147 lb 4/17/2006 Pharmacist United States
Primary
Concomitant
Injection Site Pain 1/1/2006 49 Female 285 lb 4/17/2006 Consumer United States
Primary
Concomitant
Nausea 12/1/2005 69 Male 195 lb 4/17/2006 Consumer United States
Primary
Concomitant
Stress At Work 3/11/2006 57 Male 183 lb 4/17/2006 Consumer United States
Primary
Concomitant
Pruritus 12/22/2005 52 Female 200 lb 4/17/2006 Consumer United States
Primary
Concomitant
Weight Decreased 11/1/2005 50 Female 191 lb 4/17/2006 Consumer United States
Primary
Concomitant
Weight Decreased 12/30/2005 70 Female 257 lb 4/17/2006 Consumer United States
Primary
Concomitant
Weight Decreased 8/19/2005 58 Male 205 lb 4/17/2006 Consumer United States
Primary
Concomitant
Nausea 12/31/2005 54 Female 150 lb 4/17/2006 Consumer United States
Primary
Concomitant
Weight Decreased 11/27/2005 75 Female 190 lb 4/17/2006 Consumer United States
Primary
Concomitant
Feeling Jittery 1/14/2006 56 Male 283 lb 4/17/2006 Consumer United States
Primary
Concomitant
Somnolence 1/1/2006 76 Female 200 lb 4/17/2006 Consumer United States
Primary
Concomitant
Injection Site Pain 57 Male 210 lb 4/17/2006 Consumer United States
Primary
Concomitant
Nervousness 3/1/2006 73 Female 225 lb 4/17/2006 Consumer United States
Primary
Concomitant
Weight Decreased 11/1/2005 51 Female 320 lb 4/17/2006 Consumer United States
Primary
Concomitant
Drug Ineffective For Unapproved Indication 2/24/2006 62 Male 4/17/2006 Consumer United States
Primary
Concomitant
Nausea 3/29/2006 45 Female 370 lb 4/17/2006 Consumer United States
Primary
Concomitant
Blood Glucose Increased 3/25/2006 43 Female 4/17/2006 Consumer United States
Primary
Concomitant
Hyperhidrosis 1/1/2006 67 Female 4/17/2006 Consumer United States
Primary
Concomitant
Weight Decreased 3/3/2006 51 Female 151 lb 4/17/2006 Consumer United States
Primary
Concomitant
Injection Site Pain 42 Male 212 lb 4/17/2006 Consumer United States
Primary
Concomitant
Weight Decreased Other Serious 6/18/2005 79 Female 6/20/2006 United States
Primary
Concomitant
Tremor 8/1/2005 50 Female 245 lb 4/17/2006 Consumer United States
Primary
Concomitant
Blood Glucose Increased 2/19/2006 62 Male 300 lb 4/17/2006 Consumer United States
Primary
Concomitant
Weight Decreased 1/26/2006 48 Female 231 lb 4/17/2006 Consumer United States
Primary
Concomitant
Metrorrhagia 1/21/2006 56 Female 174 lb 4/17/2006 Other Health Professional United States
Primary
Concomitant
Injection Site Bruising 2/1/2006 62 Female 4/17/2006 Consumer United States
Primary
Concomitant
Tremor 3/1/2006 66 Female 244 lb 4/17/2006 Consumer United States
Primary
Concomitant
Nausea 3/14/2006 70 Male 4/17/2006 Consumer United States
Primary
Concomitant
Weight Increased 2/21/2006 57 Male 237 lb 4/17/2006 Consumer United States
Primary
Concomitant
Nausea 1/1/2006 71 Female 180 lb 4/17/2006 Consumer United States
Primary
Concomitant
Heart Rate Decreased Other Serious 1/7/2006 Male 275 lb 7/8/2006 United States
Primary
Secondary
Concomitant
No Adverse Effect 1/1/2006 46 Male 213 lb 4/17/2006 Consumer United States
Primary
Concomitant
Blood Glucose Increased 2/17/2006 68 Male 257 lb 4/17/2006 Consumer United States
Primary
Concomitant
Weight Decreased 1/29/2006 49 Female 203 lb 4/17/2006 Consumer United States
Primary
Concomitant
Blood Glucose Increased 3/8/2006 Male 4/17/2006 Consumer United States
Primary
Concomitant
Injection Site Haemorrhage 10/1/2005 53 Male 247 lb 4/17/2006 Consumer United States
Primary
Concomitant
Rectal Haemorrhage Other Serious 12/11/2005 66 Female 180 lb 7/17/2006 United States
Primary
Concomitant
Mobility Decreased Other Serious 6/1/2006 63 Female 7/11/2006 Consumer United States
Primary
Concomitant
Drug Ineffective 64 Male 6/6/2006 United States
Primary
Concomitant
Weight Increased 66 Female 7/21/2006 Consumer United States
Primary
Concomitant
Weight Increased Other Serious 5/7/2005 70 Male 297 lb 7/21/2006 Consumer United States
Primary
Concomitant
Drug Ineffective 4/1/2005 47 Female 7/21/2006 Consumer United States
Primary
Concomitant
Swelling 7/1/2004 Female 7/21/2006 Consumer United States
Primary
Concomitant
Oedema Other Serious 81 Female 7/21/2006 Consumer United States
Primary
Concomitant
Headache 8/10/2005 39 Female 7/21/2006 Consumer United States
Primary
Concomitant
Weight Increased 71 Female 7/21/2006 Consumer United States
Primary
Secondary
Concomitant
Vision Blurred 8/1/2005 68 Female 7/21/2006 Consumer United States
Primary
Concomitant
Oedema Peripheral 4/1/2005 46 Female 7/21/2006 Consumer United States
Primary
Concomitant
Abdominal Distension 1/1/2005 56 Male 7/21/2006 Consumer United States
Primary
Concomitant
Blood Glucose Increased 10/18/2005 42 Male 7/21/2006 Consumer United States
Primary
Concomitant
Pharmaceutical Product Complaint 9/20/2005 74 Female 7/21/2006 Consumer United States
Primary
Concomitant
Weight Increased Male 7/21/2006 Consumer United States
Primary
Concomitant

Drug Data